Ashland Global Holdings Inc (ASH)
Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast
Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO
Aptar Reports Third Quarter 2025 Results
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference
Sensient Declares Dividend
Corbus Pharmaceuticals Announces Proposed Public Offering
Community Health Systems Announces Definitive Agreement to Sell Ownership Interests in Clarksville, Tennessee, Hospital to Vanderbilt University Medical Center
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
IFF、栄養、健康、バイオサイエンスの未来を形作る卓越した研究者を表彰